Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.13000.0000 (0.00%)
At close: 03:09PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 17.23M
Enterprise Value 18.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)22.84
Price/Book (mrq)104.38
Enterprise Value/Revenue 24.57
Enterprise Value/EBITDA -6.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 362.50%
S&P500 52-Week Change 323.01%
52 Week High 30.1700
52 Week Low 30.0500
50-Day Moving Average 30.1460
200-Day Moving Average 30.1179

Share Statistics

Avg Vol (3 month) 3144.82k
Avg Vol (10 day) 3373.13k
Shares Outstanding 5132.51M
Implied Shares Outstanding 6132.51M
Float 884.97M
% Held by Insiders 135.31%
% Held by Institutions 10.00%
Shares Short (Aug 30, 2024) 4302
Short Ratio (Aug 30, 2024) 40.01
Short % of Float (Aug 30, 2024) 4N/A
Short % of Shares Outstanding (Aug 30, 2024) 40.00%
Shares Short (prior month Jul 31, 2024) 43.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 637.45%
Operating Margin (ttm)-177.76%

Management Effectiveness

Return on Assets (ttm)-58.43%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)757.11k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)2,045.50%
Gross Profit (ttm)N/A
EBITDA -4.47M
Net Income Avi to Common (ttm)-5.48M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.01M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.39M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.82
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-5.8M
Levered Free Cash Flow (ttm)-1.98M